MEDICINE: Large Risk Reduction For Rivaroxaban In Blood Clot Prevention

Audio Journal of Medicine, December 8th, 2007 Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta Large Risk Reduction For Rivaroxaban In Blood Clot Prevention BENGT ERIKSSON, Gothenburg University REFERENCE: Abstract 6 In a large phase III trial of patients having a hip replacement, the oral anticoagulant rivaroxaban has shown significant benefit when compared to enoxaparin. Derek Thorne heard more from Bengt Eriksson of Gothenburg University.

You can listen to MEDICINE: Large Risk Reduction For Rivaroxaban In Blood Clot Prevention online on Radio and Podcast. Open the player on this page to stream the available audio.

MEDICINE: Large Risk Reduction For Rivaroxaban In Blood Clot Prevention is an episode from Audio Medica News - Medical News Interviews by Audio Medica.

This episode is 00:03:50 long.

This episode was published on Dec 9, 2007.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Audio Medica News - Medical News Interviews when more episodes are available from the podcast feed.